Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
0.8922
+0.0060 (0.68%)
Jun 10, 2026, 2:17 PM EDT - Market open
Standard BioTools Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 86.26 | 85.33 | 91.01 | 106.34 | 97.95 | 130.58 | |
Revenue Growth (YoY) | -3.71% | -6.24% | -14.42% | 8.57% | -24.99% | -5.47% |
Cost of Revenue | 43.45 | 42.79 | 46.13 | 55.89 | 60.9 | 61.21 |
Gross Profit | 42.8 | 42.54 | 44.88 | 50.45 | 37.05 | 69.37 |
Selling, General & Admin | 98.64 | 109.86 | 103.06 | 87.54 | 102.29 | 98.89 |
Research & Development | 22.66 | 25.99 | 28.83 | 25.95 | 37.38 | 37.94 |
Other Operating Expenses | 17.27 | 16.94 | 40.48 | 13.56 | 13.59 | - |
Total Operating Expenses | 138.58 | 152.79 | 172.37 | 127.05 | 153.26 | 136.83 |
Operating Income | -95.78 | -110.25 | -127.49 | -76.6 | -116.21 | -67.46 |
Interest Income | 9.77 | 9.18 | 20.2 | 5.57 | 2.23 | 7.14 |
Interest Expense | -0.02 | -0.03 | -3.32 | -4.57 | -4.33 | -3.82 |
Other Non-Operating Income (Expense) | -1.8 | 4.39 | 20.21 | 1.39 | -74.62 | 0.48 |
Total Non-Operating Income (Expense) | 7.95 | 13.55 | 37.09 | 2.4 | -76.72 | 3.8 |
Pretax Income | -87.83 | -96.7 | -90.4 | -74.2 | -192.93 | -63.66 |
Provision for Income Taxes | -37.75 | -37.88 | 0.54 | 0.45 | -2.83 | -4.42 |
Net Income | 78.21 | -74.9 | -138.89 | -74.66 | -190.1 | -59.24 |
Earnings From Discontinued Operations | 128.29 | -16.07 | -47.95 | - | - | - |
Net Income to Common | 29.34 | -149.79 | -46.01 | -149.31 | -380.2 | -59.24 |
Shares Outstanding (Basic) | 384 | 382 | 353 | 79 | 78 | 78 |
Shares Outstanding (Diluted) | 384 | 382 | 353 | 79 | 78 | 78 |
Shares Change (YoY) | 2.66% | 8.03% | 346.24% | 1.09% | - | 8.69% |
EPS (Basic) | 0.20 | -0.20 | -0.52 | -0.94 | -2.43 | -0.64 |
EPS (Diluted) | 0.20 | -0.20 | -0.52 | -0.94 | -2.43 | -0.64 |
Shares Outstanding | 390.14 | 386.38 | 377.53 | 80.23 | 79.48 | 76.92 |
Free Cash Flow | -94.48 | -82.65 | -151.81 | -46.12 | -93.2 | -57.33 |
Free Cash Flow Per Share | -0.25 | -0.22 | -0.43 | -0.58 | -1.19 | -0.73 |
Gross Margin | 49.62% | 49.86% | 49.32% | 47.44% | 37.83% | 53.13% |
Operating Margin | -111.04% | -129.20% | -140.08% | -72.03% | -118.64% | -51.66% |
Profit Margin | 90.67% | -87.77% | -152.61% | -70.20% | -194.08% | -45.36% |
FCF Margin | -109.53% | -96.85% | -166.81% | -43.37% | -95.15% | -43.90% |
EBITDA | -87.56 | -99.27 | -110.62 | -61.42 | -101.18 | -51.89 |
EBITDA Margin | -101.51% | -116.34% | -121.55% | -57.76% | -103.30% | -39.74% |
EBIT | -95.78 | -110.25 | -127.49 | -76.6 | -116.21 | -67.46 |
EBIT Margin | -111.04% | -129.20% | -140.08% | -72.03% | -118.64% | -51.66% |
Effective Tax Rate | 42.98% | 39.17% | -0.60% | -0.61% | 1.47% | 6.95% |